Problem statement: Answer the multiple choice question.
Question: Which drug exhibits a 5.602\% human ether-à-go-go related gene (hERG) inhibition at a concentration of 1uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any additional words.
Options:
a COc1ccccc1-c1ccc(SCc2ccccc2)nn1
b CCCCNc1nc2c(c(=O)n(C)c(=O)n2C)n1Cc1cccc(OC)c1
c O=C(Nc1nc2c(s1)CCCC2)c1ccc(N2C(=O)CCC2=O)cc1
d CCOc1ccccc1C(=O)N[C@H](C(=O)OCc1cc(=O)oc2cc(C)ccc12)C(C)C
Answer: c. O=C(Nc1nc2c(s1)CCCC2)c1ccc(N2C(=O)CCC2=O)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
4-(2,5-dioxopyrrolidin-1-yl)-N-(4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)benzamide